←Back to Expert Scholars
Translational Medicine / 转化医学Colorectal Cancer Early Detection, Stool DNA Testing
Thomas Imperiale
MD
🏢Indiana University School of Medicine🌐USA
Professor of Medicine
65
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Thomas Imperiale led the pivotal DeeP-C trial that compared multi-target stool DNA testing (Cologuard) against FIT for CRC screening. His work has informed guideline inclusion of noninvasive CRC screening tests. He is professor of medicine at Indiana University.
Share:
🧪Research Fields 研究领域
multi-target stool DNA
Cologuard pivotal trial
FIT performance
risk prediction
CRC diagnostics
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Thomas Imperiale 的研究动态
Follow Thomas Imperiale's research updates
留下邮箱，当我们发布与 Thomas Imperiale（Indiana University School of Medicine）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment